[go: up one dir, main page]

DE69927524D1 - Topoisomerase-ii inhibitoren - Google Patents

Topoisomerase-ii inhibitoren

Info

Publication number
DE69927524D1
DE69927524D1 DE69927524T DE69927524T DE69927524D1 DE 69927524 D1 DE69927524 D1 DE 69927524D1 DE 69927524 T DE69927524 T DE 69927524T DE 69927524 T DE69927524 T DE 69927524T DE 69927524 D1 DE69927524 D1 DE 69927524D1
Authority
DE
Germany
Prior art keywords
glu
leu
lys
gln
topoisomerase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69927524T
Other languages
English (en)
Inventor
Serge Fermandjian
Valerie Frere-Gallois
Frederic Troalen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Application granted granted Critical
Publication of DE69927524D1 publication Critical patent/DE69927524D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90Isomerases (5.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
DE69927524T 1998-12-22 1999-12-20 Topoisomerase-ii inhibitoren Expired - Lifetime DE69927524D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816264A FR2787454B1 (fr) 1998-12-22 1998-12-22 Inhibiteur de la topoisomerase ii
PCT/FR1999/003208 WO2000037499A1 (fr) 1998-12-22 1999-12-20 Inhibiteur de la topoisomerase ii

Publications (1)

Publication Number Publication Date
DE69927524D1 true DE69927524D1 (de) 2006-02-09

Family

ID=9534347

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69927524T Expired - Lifetime DE69927524D1 (de) 1998-12-22 1999-12-20 Topoisomerase-ii inhibitoren

Country Status (8)

Country Link
US (1) US6562788B1 (de)
EP (1) EP1141006B1 (de)
JP (1) JP2002534358A (de)
AT (1) ATE305478T1 (de)
AU (1) AU1783900A (de)
DE (1) DE69927524D1 (de)
FR (1) FR2787454B1 (de)
WO (1) WO2000037499A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104356206B (zh) * 2011-05-06 2017-07-14 上海医药工业研究院 Hrp5类似物及其制备方法

Also Published As

Publication number Publication date
WO2000037499A1 (fr) 2000-06-29
US6562788B1 (en) 2003-05-13
FR2787454A1 (fr) 2000-06-23
AU1783900A (en) 2000-07-12
EP1141006B1 (de) 2005-09-28
JP2002534358A (ja) 2002-10-15
EP1141006A1 (de) 2001-10-10
FR2787454B1 (fr) 2002-02-15
ATE305478T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
EP1531791A4 (de) PRûVENTION UND VERRINGERUNG VON BLUTVERLUST
ATE368053T1 (de) Antimikrobielle peptide
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
DK0883687T3 (da) C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
DE69417252D1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
AU1633200A (en) Human parathyroid hormone modifications, preparation and use
NO942553D0 (no) Ny humanproteaseinhibitor av Kunitz-type og varianter derav
EP2011510A3 (de) Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
DK1009750T3 (da) Nye (alfa-aminophosphino)peptid derivater, fremgangsmåde til deres fremstilling og deres terapeutiske anvendelse
WO2004014937A3 (en) Thrombin peptide derivatives
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
DE69927524D1 (de) Topoisomerase-ii inhibitoren
AU2865801A (en) Therapeutic peptides
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
ATE46173T1 (de) Pharmakologisch aktive peptide.
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
EP1225184A4 (de) Menschliche antithrombin-varianten
TH26711A (th) " สิ่งที่คล้ายกันของปัจจัยหลั่งฮอโมนของการเจริญเติบโต "
IL150045A0 (en) Compositions and methods for detecting stress-inducible proteins
CY1115911T1 (el) Τροποποιημενα πολυπεπτιδια περιοχης kunitz και η χρηση τους στην μειωση της ισχαιμιας ή της εκκινησης μιας συστημικης φλεγμονωδους ανταποκρισης που σχετιζεται με μια χειρουργικη επεμβαση
ATE303438T1 (de) Menschlicher cysteinyl leukotrien rezeptor 2 (cyslt2)
EP1225183A3 (de) Humaner G-Protein gekoppelter Rezeptor
TH56074A3 (th) ตัวยับยั้ง อัลฟาv เบตา6 อินทีกริน

Legal Events

Date Code Title Description
8332 No legal effect for de